I think we should have a separate thread to unpack Roger's latest interview.
I think he was quite reluctant to make any bold statements, but he did provide a nod and a wink to the ultimate ambition which is success of MPL as a Human Cancer therapeutic. All along, that has been PAA's major goal, and if we can achieve our niche in the Human Cancer market, then shareholders will be reaping out-sized benefits.
My overall impression is that he was doing a balancing act - providing basic information to new investors while also attempting to bolster and re-assure existing shareholders.
- Forums
- ASX - By Stock
- PAA
- Clinical Trials Interview June 2022
Clinical Trials Interview June 2022
-
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
16.0¢ |
Change
0.005(3.23%) |
Mkt cap ! $77.79M |
Open | High | Low | Value | Volume |
16.0¢ | 16.0¢ | 15.5¢ | $244.5K | 1.554M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 306564 | 15.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 46887 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 306564 | 0.155 |
15 | 412837 | 0.150 |
3 | 106155 | 0.145 |
5 | 123031 | 0.140 |
2 | 104000 | 0.125 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 46887 | 3 |
0.165 | 255103 | 4 |
0.170 | 210405 | 4 |
0.175 | 308034 | 4 |
0.180 | 269093 | 7 |
Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online